SRRK Scholar Rock Holding CorpcompanySEC Filings & Insider Trading Activity 2026
Latest Scholar Rock Holding Corp (SRRK) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on March 3, 2026, a 10-Q quarterly report filed on November 14, 2025, an 8-K current report filed on March 31, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Scholar Rock Holding Corp (SRRK) (SEC CIK 1727196), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business: Biopharmaceutical company developing selective monoclonal antibodies targeting latent growth factors for rare neuromuscular diseases
- • New products emphasized: Apitegromab subcutaneous formulation and SRK-439 anti-latent myostatin antibody, both in clinical development in 2026
Risk Factors
- • FDA CRL September 2025 for apitegromab due to third-party fill-finish facility GMP deficiencies, delaying BLA resubmission and potential commercialization
- • Geopolitical risk: EMA MAA review may be delayed or rejected due to mutual recognition of FDA’s OAI classification of the manufacturing site
Management Discussion & Analysis
- • Net loss $377.9M in 2025 vs $246.3M in 2024, operating expenses up 52.6% to $384.6M from $252.1M
- • R&D expense $208.4M (+12.9%), G&A expense $176.2M (+161.0%), driven by commercial launch prep for apitegromab
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-09-30)
Management Discussion & Analysis
- • No off-balance sheet arrangements during periods presented
- • Recent accounting standards reviewed; no material impact identified
Risk Factors
- • New risk: FDA CRL in Sept 2025 on third-party fill-finish facility delays apitegromab BLA resubmission and commercialization progress
- • Material update: Impact of 2025 U.S. govt staffing cuts reduces FDA review capacity, risking further regulatory delays for apitegromab
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Conference call scheduled 8:15 am ET on March 3, 2026 to report full-year 2025 financial and operating results
- • Slides (Exhibit 99.1) will accompany the call — key venue for pipeline/business updates from SRRK management
Item 2.02: Results of Operations and Financial Condition
- • Full-year 2025 financial and operating results disclosed via press release (Exhibit 99.1)
- • Filing date March 3, 2026; reporting period covers fiscal year ended December 31, 2025
Item 2.02: Results of Operations and Financial Condition
- • Full-year 2025 earnings release issued March 3, 2026 — details in Exhibit 99.1
- • Key financials (revenue, net loss, cash runway) available in the press release, critical for a clinical-stage biotech tracking burn rate
Item 7.01: Regulation FD Disclosure
- • Conference call scheduled March 3, 2026 at 8:15am ET to present full-year 2025 financial and operating results
- • Slides (Exhibit 99.1) will accompany the call — key venue for pipeline/commercial updates investors should monitor
Annual Reports Archive10-K
AI-powered analysis of Scholar Rock Holding Corp (SRRK) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of Scholar Rock Holding Corp (SRRK) 10-Q quarterly reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Scholar Rock Holding Corp (SRRK) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Profitability | |||||
| Revenue | — | $33.2M | — | — | $0 |
| Operating Income | -$129.9M | -$134.4M | -$171.3M | -$252.1M | -$384.6M |
| Net Income | — | -$134.5M | -$165.8M | -$246.3M | -$377.9M |
| Op. Margin | — | -404.8% | — | — | — |
| Net Margin | — | -405.2% | — | — | — |
| Balance Sheet | |||||
| Total Assets | — | $358.2M | $311.0M | $474.9M | $404.3M |
| Equity | $172.1M | $260.2M | $225.2M | $368.6M | $245.5M |
| ROE | — | -51.7% | -73.6% | -66.8% | -154.0% |
Source: XBRL financial data from Scholar Rock Holding Corp (SRRK) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Mar 31, 2026 | — | — | — |
8-K | Mar 3, 2026 | — | Analysis | — |
8-K | Mar 3, 2026 | — | Analysis | — |
10-K | Mar 3, 2026 | Dec 31, 2025 | Analysis | |
8-K | Jan 12, 2026 | — | — | |
8-K | Dec 2, 2025 | — | — | |
10-Q | Nov 14, 2025 | Sep 30, 2025 | Analysis | |
10-Q | Aug 6, 2025 | Jun 30, 2025 | — | |
10-Q | May 14, 2025 | Mar 31, 2025 | — | |
10-K | Feb 27, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 12, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | — | |
10-Q | May 7, 2024 | Mar 31, 2024 | — | |
10-K | Mar 19, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 7, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | — | |
10-Q | May 9, 2023 | Mar 31, 2023 | — | |
10-K | Mar 7, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 14, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 8, 2022 | Jun 30, 2022 | — | |
10-Q | May 16, 2022 | Mar 31, 2022 | — | |
10-K | Mar 7, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 9, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 10, 2021 | Jun 30, 2021 | — | |
10-Q | May 13, 2021 | Mar 31, 2021 | — |
Frequently Asked Questions
What are the latest SRRK SEC filings in 2026?
Scholar Rock Holding Corp (SRRK) has filed a 10-K annual report on March 3, 2026, a 10-Q quarterly report on November 14, 2025, an 8-K current report on March 31, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did SRRK file its most recent 10-K annual report?
Scholar Rock Holding Corp (SRRK) filed its most recent 10-K annual report on March 3, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view SRRK 10-Q quarterly reports?
Scholar Rock Holding Corp (SRRK)'s most recent 10-Q quarterly report was filed on November 14, 2025. SignalX displays every SRRK 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has SRRK filed recently?
Scholar Rock Holding Corp (SRRK)'s most recent 8-K was filed on March 31, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find SRRK insider trading activity (Form 4)?
SignalX aggregates every SRRK Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does SRRK file with the SEC?
Scholar Rock Holding Corp (SRRK) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new SRRK filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Scholar Rock Holding Corp (SRRK).
What is SRRK's SEC CIK number?
Scholar Rock Holding Corp (SRRK)'s SEC CIK (Central Index Key) number is 1727196. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1727196 to look up all SRRK filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find SRRK return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Scholar Rock Holding Corp (SRRK) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Scholar Rock Holding Corp SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 36+ filings.